{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:55:48Z","timestamp":1787504148178,"version":"build-2736575974"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T00:00:00Z","timestamp":1652227200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ebiom.2022.104076","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T01:28:54Z","timestamp":1653528534000},"page":"104076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Skin alpha-synuclein deposit patterns: A predictor of Parkinson's disease subtypes"],"prefix":"10.1016","volume":"80","author":[{"given":"Yihang","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ebiom.2022.104076_bib0001","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.bbapap.2019.03.001","article-title":"\u03b1-Synuclein misfolding and aggregation: implications in Parkinson\u2019s disease pathogenesis","volume":"1867","author":"Mehra","year":"2019","journal-title":"Biochim Biophys Acta (BBA) Proteins Proteom"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104076_bib0002","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.tibs.2020.11.007","article-title":"Mitochondrial dysfunction and mitophagy in parkinson's disease: from mechanism to therapy","volume":"46","author":"Malpartida","year":"2021","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.ebiom.2022.104076_bib0003","doi-asserted-by":"crossref","unstructured":"Ho MS. Microglia in Parkinson's disease. Adv Exp Med Biol. 2019(1175):335\u201353.","DOI":"10.1007\/978-981-13-9913-8_13"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104076_bib0004","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13031","article-title":"Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease","volume":"18","author":"Trist","year":"2019","journal-title":"Aging Cell"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104076_bib0005","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s12264-017-0183-5","article-title":"Biomarkers for Parkinson's disease: recent advancement","volume":"33","author":"Lotankar","year":"2017","journal-title":"Neurosci Bull"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104076_bib0006","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/jnc.13234","article-title":"The phosphorylation of \u03b1-synuclein: development and implication for the mechanism and therapy of the Parkinson's disease","volume":"135","author":"Xu","year":"2015","journal-title":"J Neurochem"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104076_bib0007","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-022-04240-2","article-title":"Initiation and progression of \u03b1-synuclein pathology in Parkinson's disease","volume":"79","author":"Tofaris","year":"2022","journal-title":"Cell Mol Life Sci"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104076_bib0008","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1093\/brain\/awaa238","article-title":"Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study","volume":"143","author":"Horsager","year":"2020","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104076_bib0009","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1002\/mds.27110","article-title":"Diagnostic utility of cerebrospinal fluid \u03b1-synuclein in Parkinson's disease: a systematic review and meta-analysis","volume":"32","author":"Eusebi","year":"2017","journal-title":"Mov Disord"},{"key":"10.1016\/j.ebiom.2022.104076_bib0010","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.parkreldis.2019.03.003","article-title":"The aggregation state of \u03b1-synuclein deposits in dermal nerve fibers of patients with Parkinson's disease resembles that in the brain","volume":"64","author":"Kuzkina","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104076_bib0011","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00401-014-1284-0","article-title":"Cutaneous neuropathy in Parkinson's disease: a window into brain pathology","volume":"128","author":"Doppler","year":"2014","journal-title":"Acta Neuropathol"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104076_bib0012","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","article-title":"Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen","volume":"110","author":"Braak","year":"2003","journal-title":"J Neural Transm"},{"issue":"7","key":"10.1016\/j.ebiom.2022.104076_bib0013","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/brain\/aws133","article-title":"Alterations in axonal transport motor proteins in sporadic and experimental Parkinson's disease","volume":"135","author":"Chu","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.ebiom.2022.104076_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2021.105332","article-title":"Dermal and cardiac autonomic fiber involvement in Parkinson's disease and multiple system atrophy","volume":"153","author":"Brumberg","year":"2021","journal-title":"Neurobiol Dis"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104076_bib0015","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.ebiom.2022.104076_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fneur.2019.00111","article-title":"Increased intraepidermal nerve fiber degeneration and impaired regeneration relate to symptoms and deficits in Parkinson\u2019s disease","volume":"10","author":"Jeziorska","year":"2019","journal-title":"Front Neurol"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104076_bib0017","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.24567","article-title":"Skin nerve misfolded \u03b1-synuclein in pure autonomic failure and Parkinson disease","volume":"79","author":"Donadio","year":"2016","journal-title":"Ann Neurol"},{"issue":"30","key":"10.1016\/j.ebiom.2022.104076_bib0018","doi-asserted-by":"crossref","first-page":"21742","DOI":"10.1074\/jbc.M113.451815","article-title":"\u03b1-synuclein oligomers impair neuronal Microtubule-Kinesin interplay","volume":"288","author":"Prots","year":"2013","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104076_bib0019","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10286-018-0581-4","article-title":"Skin nerve \u03b1-synuclein deposits in Parkinson's disease and other synucleinopathies: a review","volume":"29","author":"Donadio","year":"2019","journal-title":"Clin Auton Res"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104076_bib0020","article-title":"Skin \u03b1-synuclein deposits differ in clinical variants of synucleinopathy: an in vivo study","volume":"8","author":"Donadio","year":"2018","journal-title":"Sci Rep UK"},{"issue":"9","key":"10.1016\/j.ebiom.2022.104076_bib0021","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/bioinformatics\/btu848","article-title":"PRSice: polygenic risk score software","volume":"31","author":"Euesden","year":"2015","journal-title":"Bioinformatics"},{"issue":"9766","key":"10.1016\/j.ebiom.2022.104076_bib0022","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/S0140-6736(10)62345-8","article-title":"Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies","volume":"377","year":"2011","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104076_bib0023","article-title":"A two-stage meta-analysis identifies several new loci for Parkinson's disease","volume":"7","year":"2011","journal-title":"PLoS Genet"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104076_bib0024","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s40120-019-00152-9","article-title":"Neurogenic orthostatic hypotension in Parkinson disease: a primer","volume":"8","author":"Cutsforth-Gregory","year":"2019","journal-title":"Neurol Ther"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104076_bib0025","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cger.2019.09.002","article-title":"Orthostatic hypotension in Parkinson disease","volume":"36","author":"Palma","year":"2020","journal-title":"Clin Geriatr Med"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104076_bib0026","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/mds.27268","article-title":"Autonomic dysfunction in Parkinson's disease: a prospective cohort study","volume":"33","author":"Merola","year":"2018","journal-title":"Mov Disord"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104076_bib0027","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1093\/jnen\/nly074","article-title":"Skin nerve phosphorylated \u03b1-synuclein deposits in Parkinson disease with orthostatic hypotension","volume":"77","author":"Donadio","year":"2018","journal-title":"J Neuropathol Exp Neurol"},{"issue":"9","key":"10.1016\/j.ebiom.2022.104076_bib0028","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/mds.28126","article-title":"Skin biopsy may help to distinguish multiple system Atrophy\u2013Parkinsonism from Parkinson's disease with orthostatic hypotension","volume":"35","author":"Donadio","year":"2020","journal-title":"Mov Disord"},{"issue":"7","key":"10.1016\/j.ebiom.2022.104076_bib0029","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/jnen\/nlaa048","article-title":"A longitudinal skin biopsy study of phosphorylated alpha-synuclein in a patient with parkinson disease and orthostatic hypotension","volume":"79","author":"Infante","year":"2020","journal-title":"J Neuropathol Exp Neurol"},{"issue":"5","key":"10.1016\/j.ebiom.2022.104076_bib0030","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1093\/jnen\/nlx021","article-title":"Spine topographical distribution of skin \u03b1-synuclein deposits in idiopathic Parkinson disease","volume":"76","author":"Donadio","year":"2017","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104076_bib0031","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/brain\/awaa008","article-title":"\u03b1-synuclein oligomers in skin biopsy of idiopathic and monozygotic twin patients with Parkinson's disease","volume":"143","author":"Mazzetti","year":"2020","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104076_bib0032","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/brain\/awv040","article-title":"Direct visualization of alpha-synuclein oligomers reveals previously undetected pathology in Parkinson's disease brain","volume":"138","author":"Roberts","year":"2015","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104076_bib0033","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00401-017-1755-1","article-title":"Alpha-synuclein oligomers: a new hope","volume":"134","author":"Bengoa-Vergniory","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"149","key":"10.1016\/j.ebiom.2022.104076_bib0034","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.cell.2012.03.037","article-title":"Direct observation of the interconversion of normal and toxic forms of a-synuclein","author":"Nunilo Cremades","year":"2012","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104076_bib0035","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1002\/mds.28667","article-title":"\u03b1-synuclein deposition in sympathetic nerve fibers in genetic forms of Parkinson's disease","volume":"36","author":"Isonaka","year":"2021","journal-title":"Mov Disord"},{"issue":"12","key":"10.1016\/j.ebiom.2022.104076_bib0036","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(19)30320-5","article-title":"Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies","volume":"18","author":"Vallerga","year":"2019","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.ebiom.2022.104076_bib0037","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1042\/BST20180462","article-title":"LRRK2 links genetic and sporadic Parkinson's disease","volume":"47","author":"Kluss","year":"2019","journal-title":"Biochem Soc Trans"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104076_bib0038","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/acn3.51301","article-title":"Peripheral synucleinopathy in Parkinson disease with LRRK2 G2385R variants","volume":"8","author":"Yang","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104076_bib0039","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/acn3.669","article-title":"Cervical skin denervation associates with alpha-synuclein aggregates in Parkinson disease","volume":"5","author":"Melli","year":"2018","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"10.1016\/j.ebiom.2022.104076_bib0040","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1007\/s13760-020-01473-5","article-title":"Genetics of Parkinson's disease","volume":"120","author":"Cherian","year":"2020","journal-title":"Acta Neurol Belg"},{"issue":"29","key":"10.1016\/j.ebiom.2022.104076_bib0041","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.neulet.2017.08.040","article-title":"The GBA variant E326K is associated with Parkinson\u2019s disease and explains a genome-wide association signal","volume":"658","author":"Berge-Seidl","year":"2017","journal-title":"Neurosci Lett"},{"issue":"4","key":"10.1016\/j.ebiom.2022.104076_bib0042","doi-asserted-by":"crossref","first-page":"364","DOI":"10.3390\/cells8040364","article-title":"GBA, gaucher disease, and Parkinson's disease: from genetic to clinic to new therapeutic approaches","volume":"8","author":"Riboldi","year":"2019","journal-title":"Cells"},{"issue":"17","key":"10.1016\/j.ebiom.2022.104076_bib0043","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2022.104076_bib0044","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mcn.2015.03.013","article-title":"Glucocerebrosidase and Parkinson disease: recent advances","volume":"66","author":"Schapira","year":"2015","journal-title":"Mol Cell Neurosci"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104076_bib0045","doi-asserted-by":"crossref","DOI":"10.1186\/s13024-019-0336-2","article-title":"Glucocerebrosidase and its relevance to Parkinson disease","volume":"14","author":"Do","year":"2019","journal-title":"Mol Neurodegener"},{"issue":"3","key":"10.1016\/j.ebiom.2022.104076_bib0046","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/mds.26071","article-title":"GBA-associated Parkinson's disease: reduced survival and more rapid progression in a prospective longitudinal study","volume":"30","author":"Brockmann","year":"2014","journal-title":"Mov Disord"},{"issue":"8","key":"10.1016\/j.ebiom.2022.104076_bib0047","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/mds.26278","article-title":"No evidence for substrate accumulation in Parkinson brains with GBA mutations","volume":"30","author":"Gegg","year":"2015","journal-title":"Mov Disord"},{"issue":"11","key":"10.1016\/j.ebiom.2022.104076_bib0048","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/ene.13395","article-title":"GBA mutations in Parkinson disease: earlier death but similar neuropathological features","volume":"24","author":"Adler","year":"2017","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ebiom.2022.104076_bib0049","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2018.01094","article-title":"Dermal phospho-alpha-synuclein deposition in patients with Parkinson's disease and mutation of the glucocerebrosidase gene","volume":"9","author":"Doppler","year":"2018","journal-title":"Front Neurol"},{"issue":"149","key":"10.1016\/j.ebiom.2022.104076_bib0050","first-page":"207","article-title":"Atypical' Parkinson's disease - genetic","volume":"149","author":"Anne Weissbacha","year":"2019","journal-title":"Int Rev Neurobiol"},{"issue":"24","key":"10.1016\/j.ebiom.2022.104076_bib0051","doi-asserted-by":"crossref","first-page":"7107","DOI":"10.1021\/bi7000246","article-title":"The impact of the E46K mutation on the properties of \u03b1-synuclein in its monomeric and oligomeric states","volume":"46","author":"Fredenburg","year":"2007","journal-title":"Biochemistry"},{"issue":"39","key":"10.1016\/j.ebiom.2022.104076_bib0052","doi-asserted-by":"crossref","first-page":"E8274","DOI":"10.1073\/pnas.1703420114","article-title":"E46K \u03b1-synuclein pathological mutation causes cell-autonomous toxicity without altering protein turnover or aggregation","volume":"114","author":"\u00cd\u00f1igo-Marco","year":"2017","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"10.1016\/j.ebiom.2022.104076_bib0053","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.parkreldis.2012.08.001","article-title":"Cardiac sympathetic denervation in symptomatic and asymptomatic carriers of the E46K mutation in the \u03b1-synuclein gene","volume":"19","author":"Tijero","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"issue":"1-2","key":"10.1016\/j.ebiom.2022.104076_bib0054","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jns.2011.07.047","article-title":"Initial neuropsychological impairments in patients with the E46K mutation of the \u03b1-synuclein gene (PARK 1)","volume":"310","author":"Somme","year":"2011","journal-title":"J Neurol Sci"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104076_bib0055","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/mds.20581","article-title":"Abnormal sleep architecture is an early feature in the E46K familial synucleinopathy","volume":"20","author":"Zarranz","year":"2005","journal-title":"Mov Disord"},{"key":"10.1016\/j.ebiom.2022.104076_bib0056","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.parkreldis.2019.05.038","article-title":"Small fiber neuropathy and phosphorylated alpha-synuclein in the skin of E46K-SNCA mutation carriers","volume":"65","author":"Carmona-Abellan","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"issue":"10","key":"10.1016\/j.ebiom.2022.104076_bib0057","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/mds.27794","article-title":"Value of in vivo \u03b1-synuclein deposits in Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"34","author":"Tsukita","year":"2019","journal-title":"Mov Disord"},{"issue":"26","key":"10.1016\/j.ebiom.2022.104076_bib0058","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/ene.13939","article-title":"Abnormal a-synuclein deposits in skin nerves: intra- and inter-laboratory reproducibility","volume":"26","author":"Donadio","year":"2019","journal-title":"Eur J Neurol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422002572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396422002572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:14:51Z","timestamp":1762456491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396422002572"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":58,"alternative-id":["S2352396422002572"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104076","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skin alpha-synuclein deposit patterns: A predictor of Parkinson's disease subtypes","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2022.104076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104076"}}